London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
Cartilage in the temporomandibular joint can be structurally repaired rather than symptomatically masked: an ultrasound-guided collagen injection recruits progenitor cells to rebuild tissue, with clinical data showing cartilage fill verified by MRI and functional improvements of 30 points or more.
ChondroFiller is a biodegradable collagen scaffold that recruits the body's repair cells; Arthrosamid is a permanent hydrogel that cushions the joint without promoting healing. The choice depends on whether cartilage can regenerate, not on which treatment works better.
Arthroscopy confirms only 12% of suspected partial ACL tears remain partial. The intact bundle shows microscopic damage indistinguishable from complete rupture, yet treatment outcomes diverge: surgery restores superior mechanical stability for high-demand athletes, while structured conservative rehabilitation achieves equivalent functional outcomes for others.
Patients often improve at 12 months after microfracture, but symptoms recur by years two to three because the procedure recruits bone marrow cells that form fibrocartilage rather than hyaline cartilage. ChondroFiller injection adds a collagen scaffold to direct those cells toward hyaline-like tissue.
ChondroFiller is an injectable collagen scaffold that recruits the patient's own progenitor cells to repair focal cartilage defects; three-year outcomes show 32-point functional improvement on validated knee function scales.
Only one in four ACL injuries are correctly identified initially; diagnostic delays allow meniscal and cartilage damage to accumulate undetected, with measurable deterioration within six months.
